Intervention not reported
Arrhythmias Long‐term · people with chronic ischaemic heart disease and congestive heart failure
The intervention may leads to lower arrhythmias Long‐term (low certainty).
1 finding from 1 review
Intervention not reported
Composite MACE Long‐term · people with chronic ischaemic heart disease and congestive heart failure
The intervention showed no clear difference in composite MACE Long‐term (low certainty).
1 finding from 1 review
Intervention not reported
LVEF (%) measured by MRI Long‐term · people with chronic ischaemic heart disease and congestive heart failure
1 finding from 1 review
Intervention not reported
Cardiovascular mortality · people with hyperlipidaemia
1 finding from 1 review
Intervention not reported
Cardiovacular morbidity · people with hyperlipidaemia
1 finding from 1 review
Intervention not reported
At least 1 adverse event · people with hyperlipidaemia
The intervention showed no clear difference in at least 1 adverse event (low certainty).
1 finding from 1 review
Intervention not reported
Total Cholesterol (mg/dL) · people with hyperlipidaemia
1 finding from 1 review
Intervention not reported
LDL‐C (mg/dL) · people with hyperlipidaemia
1 finding from 1 review
Intervention not reported
HDL‐C (mg/dL) · people with hyperlipidaemia
1 finding from 1 review
Intervention not reported
Triglycerides (mg/dL) · people with hyperlipidaemia
1 finding from 1 review
Intervention not reported
Death (all‐causes) · Post‐menopausal women
The intervention probably leads to lower death (all‐causes) (moderate certainty).
1 finding from 1 review
Intervention not reported
Coronary heart disease (death from cardiovascular causes and non‐fatal myocardial infarction) · Post‐menopausal women
The intervention probably leads to lower coronary heart disease (death from cardiovascular causes and… (moderate certainty).
1 finding from 1 review
Intervention not reported
Stroke · Post‐menopausal women
The intervention showed no clear difference in stroke (high certainty).
1 finding from 1 review
Intervention not reported
Venous thromboembolism · Post‐menopausal women
The intervention leads to higher venous thromboembolism (high certainty).
1 finding from 1 review
Intervention not reported
Death (all‐causes) · Post‐menopausal women
The intervention showed no clear difference in death (all‐causes) (high certainty).
1 finding from 1 review
Intervention not reported
Coronary heart disease (death from cardiovascular causes and non‐fatal myocardial infarction) · Post‐menopausal women
The intervention showed no clear difference in coronary heart disease (death from cardiovascular causes and… (high certainty).
1 finding from 1 review
Intervention not reported
Stroke · Post‐menopausal women
The intervention leads to higher stroke (high certainty).
1 finding from 1 review
Intervention not reported
Venous thromboembolism · Post‐menopausal women
The intervention leads to higher venous thromboembolism (high certainty).
1 finding from 1 review
Angina reduction ‐ NYHA scale Decrease in two angina classes or more · patients with refractory angina
Transmyocardial laser revascularization may leads to higher angina reduction Decrease in two angina classes or more compared with medical treatment (low certainty).
2 findings from 1 review
Angina reduction ‐ CCS score Decrease in two angina classes or more · patients with refractory angina
Transmyocardial laser revascularization may leads to higher angina reduction ‐ CCS score Decrease in two angina classes or more compared with medical treatment (low certainty).
1 finding from 1 review